Amgen's Suit To Shield Cancer Treatment Biosimilar Tossed
A California federal judge on Friday granted a motion by Genentech to toss a complaint brought by Amgen seeking to invalidate more than two dozen patents related to Genentech's cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article